Imperial College London
Portrait Picture

Professor Mona El-Bahrawy

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Professor of Practice (Histopathology)
 
 
 
//

Contact

 

m.elbahrawy

 
 
//

Location

 

Department of HistopathologyHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Zubiaur:2018:10.1158/1557-3265.AACRIASLC18-B13,
author = {Zubiaur, IA and Montinaro, A and von, Karstedt S and Lemke, J and Hartwig, T and Taraborelli, L and Surinova, S and El-Bahrawy, MA and Walczak, H},
doi = {10.1158/1557-3265.AACRIASLC18-B13},
publisher = {AMER ASSOC CANCER RESEARCH},
title = {The impact of combined CDK9 inhibition and TRAIL treatment on NSCLC},
url = {http://dx.doi.org/10.1158/1557-3265.AACRIASLC18-B13},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Zubiaur,IA
AU  - Montinaro,A
AU  - von,Karstedt S
AU  - Lemke,J
AU  - Hartwig,T
AU  - Taraborelli,L
AU  - Surinova,S
AU  - El-Bahrawy,MA
AU  - Walczak,H
DO  - 10.1158/1557-3265.AACRIASLC18-B13
PB  - AMER ASSOC CANCER RESEARCH
PY  - 2018///
SN  - 1078-0432
TI  - The impact of combined CDK9 inhibition and TRAIL treatment on NSCLC
UR  - http://dx.doi.org/10.1158/1557-3265.AACRIASLC18-B13
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000582244900048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download